Related Experiment Video
Updated: Jan 4, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
NCCN Guidelines Insights: Kidney Cancer, Version 2.2020.
Robert J Motzer1, Eric Jonasch2, M Dror Michaelson3
1Memorial Sloan Kettering Cancer Center.
The NCCN Guidelines for Kidney Cancer offer updated 2020 recommendations for managing advanced clear cell renal cell carcinoma. These insights focus on initial treatment and first-line systemic therapy options for improved patient care.
Area of Science:
- Oncology
- Nephrology
Background:
- The National Comprehensive Cancer Network (NCCN) Guidelines for Kidney Cancer offer multidisciplinary recommendations for managing clear cell and non-clear cell renal cell carcinoma.
- These guidelines aid clinical decision-making for kidney cancer patients.
Purpose of the Study:
- To summarize the NCCN Kidney Cancer Panel discussions for the 2020 update.
- To provide insights on initial management and first-line systemic therapy for advanced clear cell renal cell carcinoma.
Main Methods:
- Review of NCCN Kidney Cancer Panel discussions.
- Analysis of updated guidelines for 2020.
Main Results:
- The 2020 update addresses initial management strategies.
- Key first-line systemic therapy options for advanced clear cell renal cell carcinoma are detailed.
Conclusions:
- The updated NCCN Guidelines provide current recommendations for treating advanced clear cell renal cell carcinoma.
- These insights support clinicians in making informed treatment decisions.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Kidney Transplant III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention

